G
Gideon Koren
Researcher at Ariel University
Publications - 2007
Citations - 88165
Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.
Papers
More filters
Journal Article
The Effects of Cocaine and Nicotine on Amino Acid Transport across the Human Placental Cotyledon Perfused In Vitro
TL;DR: Both cocaine and nicotine may contribute to fetal growth restriction by interfering with the activity of amino acids transporters that are necessary to maintain the nutrient gradients associated with normal fetal growth.
Journal ArticleDOI
Unexpected alterations in fentanyl pharmacokinetics in children undergoing cardiac surgery: age related or disease related?
TL;DR: The studies suggest that the alterations in the distribution volume of fentanyl in these children may largely depend upon the severity of the hemodynamic disturbance whereas TBC of the drug may depend on their age.
Journal ArticleDOI
Interpretation of excessive serum concentrations of digoxin in children
Gideon Koren,Ruth Parker +1 more
TL;DR: Excessive serum concentrations of digoxin may not necessarily reflect potentially toxic levels, and there was a good correlation between digoxin elimination T1/2 and serum creatine concentrations.
Journal ArticleDOI
Pharmacogenetics of opioids for the treatment of acute maternal pain during pregnancy and lactation.
TL;DR: Some interesting avenues of research require further pursuit- including evidence of cytochrome P450 2D6 (CYP2D6) induction during pregnancy and its effect on the generation of the active opioid metabolites morphine, oxymorphone, O-desmethyltramadol, and hydromorphone following the administration of codeine, oxycodone, tramadol and hydrocodone respectively.
Journal ArticleDOI
Machine learning of big data in gaining insight into successful treatment of hypertension
TL;DR: Machine learning of big data is a novel method to identify effective antihypertensive therapy and for repurposing medications already on the market for new indications and should be corroborated and affirmed by other methods.